An intraocular lens (IOL) injectors and associated methods are described. The IOL injectors may include a collapsible portion configured to reduce the length of the IOL injector when the collapsible portion is altered from an uncollapsed configuration to a collapsed configuration. In some instances, an IOL may be advanced from a storage location to a dwell location when the collapsible portion is altered from the uncollapsed configuration to the collapsed configuration. The IOL injectors may also include a combination push and screw drive.

A modular IOL system including intraocular primary and secondary components, which, when combined, form an intraocular optical correction device, wherein the secondary component is placed on the primary component within the perimeter of the capsulorhexis, thus avoiding the need to touch or otherwise manipulate the capsular bag. The secondary component may be manipulated, removed, and/or exchanged for a different secondary component for correction or modification of the optical result, on an intra-operative or post-operative basis, without the need to remove the primary component and without the need to manipulate the capsular bag. The primary component may have haptics extending therefrom for centration in the capsular bag, and the secondary component may exclude haptics, relying instead on attachment to the primary component for stability. Such attachment may include actuatable interlocking members.

An ophthalmic device includes an optic and a haptic structure coupled with the optic. The optic includes an optic axis. The haptic structure is coupled to the optic. The haptic structure retains the ophthalmic device within a capsular bag of a patient's eye. At least a portion of the haptic structure has a cross-section and a peripheral surface forming an outer periphery of a portion of the cross-section. At least a portion of the peripheral surface contacts the capsular bag and is smoothly curved.

An ophthalmic implant configured for peri-operative, intra-operative, or post-operative assembly and disassembly. Drug delivery devices may be implanted with an intraocular lens, and later removed and replaced with new drug delivery devices.

Apparatuses, systems, and methods directed to reducing negative dysphotopsia in an individual's eye. Such apparatuses, systems, and methods may include determining an angle kappa of an individual's eye. Such apparatuses, systems, and methods further include tilt adjustable intraocular lenses.

An intraocular lens comprising an optic and four haptics extending from the optic, each haptic having a proximal end meeting with the optic at differing points about a periphery of the optic. The four haptics are arranged into a first pair comprising two arcuate haptics with curvature orientated toward each other such that a distal end of each of the two haptics of the first pair are in nearer relation than their proximal ends; and, a second pair comprising two arcuate haptics with curvature orientated toward each other such that a distal end of each of the two haptics of the second pair are in nearer relation than their proximal end.

An intraocular lens (IOL) includes one or more haptic structures coupled to hold the IOL (100A) system in an eye. The IOL also includes one or more mechanical-to-electrical transducers (107) that detect mechanical changes in the eye and, in response to the mechanical changes, output an electrical signal. An accommodation actuator (101) is electrically coupled to the one or more mechanical-to-electrical transducers, and in response to the electrical signal the optical power of the accommodation actuator changes.

An artificial eye lens (1) having an optical part (2) which has a first optical side (4) and an opposite, second optical side (5). The optical part (2) has a diffractive grating structure that contributes to an optical imaging property of the optical part (2). The diffractive grating structure is an amplitude grating (6) formed in the optical part (2) as a laser structure. A method for producing an artificial eye lens (1) where the amplitude grating (6) is produced with a laser apparatus (17), and a pulsed laser beam (22) having a pulse length of between 100 fs and 20 ps, a wavelength of between 320 nm and 1100 nm, a pulse repetition rate of between 1 kHz and 10 MHz, a focus diameter of less than 5 μm, and a power density of greater than 10.sup.6 W/cm.sup.2.

An ophthalmic lens includes an optic comprising an anterior surface, a posterior surface, and an optic edge extending between the anterior surface and the posterior surface, the optic having an optical axis. The ophthalmic lens further includes a plurality of haptics extending from a periphery of the optic, each of the plurality of haptics including a gusset region, a distal region, and an elbow region connecting the gusset region to the distal region. The gusset region of each of the plurality of haptics extends from the periphery of the optic and spans a portion of the periphery of the optic. In addition, the gusset region of each of the plurality of haptics monotonically increases in thickness with increased distance from the periphery of the optic, while the distal region of each of the plurality of haptics monotonically decreases in thickness with increased distance from the elbow region.

An ophthalmic implant for drug delivery. The implant includes a primary intracapsular device coupled to a secondary device, wherein, when implanted in a patient's eye, the primary intracapsular device is held in place by the patient's capsular bag and the secondary device is held in place by the primary intracapsular device. The implant may be inserted in the eye by injecting the primary intracapsular device into the eye either before or after attaching the secondary device to the primary intracapsular device, and subsequently positioning the joined secondary device and primary intracapsular device with the primary intracapsular device held in place by the patient's capsular bag and the secondary device held in place by the primary intracapsular device. The secondary device may be designed to hold a tertiary device that can be implanted and attached at the time of surgery or anytime postoperatively.